Wistar Wire: Funding

Ben Leach
Philadelphia Inquirer
Philadelphia Inquirer
Using the Ebola virus and the need for a vaccine as a starting point, Wistar President and CEO Russel E. Kaufman, M.D., discusses how a cure for Ebola requires teams of scientists "chipping away at a stone that held a secret and then building on each other's discoveries."
Ben Leach
Dr. Meehard Herlyn will oversee the SPORE grant studies.
Dr. Meehard Herlyn will oversee the SPORE grant studies.
Dr. Meenhard Herlyn discusses the $12.1 million collaborative SPORE grant, and Dr. Scott Hensley discusses the need for seasonal flu vaccinations. We also recap the big news from the past month.
Ben Leach
Russel E. Kaufman, M.D.
Russel E. Kaufman, M.D.
“If you think research is expensive, try disease." Health care costs are soaring while the National Institutes of Health's budgets are shrinking, and for science to survive, long-term considerations must be made.
Commentary, Funding
Ben Leach
Meenhard Herlyn, D.V.M., D.Sc.
Meenhard Herlyn, D.V.M., D.Sc.
Wistar’s Dr. Meenhard Herlyn leads researchers from The Wistar Institute and the University of Pennsylvania to develop new therapies for melanoma.
Cancer, Funding, Melanoma